Serotonin syndrome resulting from serotonergic drug interactions can be successfully managed with supportive care and non-specific serotonin antagonists.
Answers are grounded in this paper and cite their sources.
Supports management of serotonin syndrome with supportive care; leaves open need for prospective studies.
We describe six patients diagnosed with serotonin syndrome after exposure to drugs with serotonergic activity. Drug interactions occurred as a result of a combination of tricyclic antidepressants, selective serotonin reuptake inhibitors, selective noradrenaline reuptake inhibitors or monoamine oxidase inhibitors. Management included supportive care and the use of non-specific serotonin antagonists (cyproheptadine, benzodiazepines and chlorpromazine). All patients made uneventful recoveries.
No takes yet. Share an insight, caveat, or question.
Chan et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: